Cipla Medpro South Africa Ltd is South Africa's 4th largest and fastest growing pharmaceutical company through its subsidiary Cipla Medpro Holdings (Pty) Ltd, which has access to one of the best pipelines in the world through a 20 year supply agreement with Cipla India, and commands a substantial share of the local chronic medicines market targeting inter alia, the respiratory, cardiovascular, ARV and diabetes markets. The group's 4 000m? MCC-approved manufacturing facility in Durban, KwaZulu-Natal has recently completed a R329 million upgrade to international PIC/S compliance.
Results
December 2010 Final estimated to be released on Friday , 18 March 2011
Market Statistics are calculated by Sharenet and are therefore not the official JSE Market Statistics. The calculation/derivation may include underlying JSE data.
